Lys-and Glu-plasminogen potentiate the inhibitory effect of recombinant tissue plasminogen activator on human platelet aggregation
- 15 June 1994
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 74 (6) , 555-563
- https://doi.org/10.1016/0049-3848(94)90213-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Enhancement of the thrombolytic efficacy of prourokinase by lys-plasminogen in a dog model of arterial thrombosisThrombosis Research, 1991
- Iloprost and tissue-type plasminogen activator differently affect platelet aggregation in platelet-rich plasma and in whole bloodThrombosis Research, 1990
- Inhibition of intravascular platelet aggregation by endothelium-derived relaxing factor: reversal by red blood cellsBlood, 1990
- Tissue-type plasminogen activator inhibits aggregation of plateletsLife Sciences, 1988
- Tissue plasminogen activator promotes platelet disaggregation in plasma.Journal of Clinical Investigation, 1987
- Plasmin inhibition of platelet function and of arachidonic acid metabolism.Journal of Clinical Investigation, 1985
- Clot retraction facilitates clot lysisBlood, 1981
- On the Regulation and Control of FibrinolysisThrombosis and Haemostasis, 1980
- On the biological significance of the specific interaction between fibrin, plasminogen and antiplasminBiochimica et Biophysica Acta (BBA) - General Subjects, 1978
- Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of plateletsJournal of Clinical Investigation, 1970